19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandra Fabi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 88 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2020, In : Breast Care. 15, p. 30-37 8 p.

Research output: Contribution to journalArticle

  • T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study: Clinical Breast Cancer

    Conte, B., Fabi, A., Poggio, F., Blondeaux, E., Dellepiane, C., D'Alonzo, A., Buono, G., Arpino, G., Magri, V., Naso, G., Presti, D., Mura, S., Fontana, A., Cognetti, F., Molinelli, C., Pastorino, S., Bighin, C., Miglietta, L., Boccardo, F., Lambertini, M. & 2 others, Del Mastro, L. & group, G. I. M. GIM. S., 2020, In : Clin. Breast Cancer.

    Research output: Contribution to journalArticle

  • A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

    Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

    Research output: Contribution to journalArticle

  • A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

    Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 1 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

    Research output: Contribution to journalArticle

  • Comorbidities in elderly patients with glioblastoma: A field-practice study

    Villani, V., Tanzilli, A., Telera, S. M., Terrenato, I., Vidiri, A., Fabi, A., Zucchella, C., Carapella, C. M., Marucci, L., Casini, B., Carosi, M., Oppido, P. M. & Pace, A., Mar 2019, In : Future Oncology. 15, 8, p. 841-850 10 p.

    Research output: Contribution to journalArticle